Staph bacteria may change the factor they use to activate blood clotting — to evade the immune response — a new study suggests.
New structural details of the binding of the bacterium Streptococcus sanguinis to platelets may offer new therapeutics for life-threatening cardiovascular infections.
Accessibility Tools